Diacylglycerol (DAG) is an important lipid second messenger. DAG signalling is terminated by conversion of DAG to phosphatidic acid (PA) by diacylglycerol kinases (DGKs). The neuronal synapse is a major site of DAG production and action; however, how DGKs are targeted to subcellular sites of DAG generation is largely unknown. We report here that postsynaptic density (PSD)-95 family proteins interact with and promote synaptic localization of DGKi. In addition, we establish that DGKi acts presynaptically, a function that contrasts with the known postsynaptic function of DGKf, a close relative of DGKi. Deficiency of DGKi in mice does not affect dendritic spines, but leads to a small increase in presynaptic release probability. In addition, DGKi À/À synapses show a reduction in metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) at neonatal (B2 weeks) stages that involve suppression of a decrease in presynaptic release probability. Inhibition of protein kinase C normalizes presynaptic release probability and mGluR-LTD at DGKi À/À synapses.
Introduction
The phospholipase C (PLC) family of enzymes hydrolyses phosphatidylinositol-4,5-bisphosphate (PIP 2 ) to diacylglycerol (DAG) and inositol trisphosphate, both of which function as important lipid signalling molecules (Rhee, 2001) . PLCs are stimulated in response to activation of various surface receptors, including G protein-coupled receptors (GPCRs) and non-GPCR receptors (Sternweis et al, 1992; Rhee, 2001) . Among the receptors at excitatory synapses that stimulate PLC are metabotropic glutamate receptors (mGluRs) and ionotropic NMDA receptors (Reyes-Harde and Stanton, 1998; Choi et al, 2005b; Horne and Dell'Acqua, 2007) . DAG activates a series of downstream effectors that contain the DAG-binding C1 domain, such as protein kinase C (PKC), UNC-13, RasGRPs, and chimaerins (Brose et al, 2004) . The functions of DAG at the synapse, however, are only beginning to be understood (Brose et al, 2004; Goto et al, 2006; Kim et al, 2009a) .
Agonist-induced DAG signalling is terminated by enzymatic conversion of DAG to phosphatidic acid (PA) by diacylglycerol kinases (DGKs). There are 10 known mammalian DGKs belonging to one of five types (type I-V), which are mostly expressed in the brain (Luo et al, 2004; Sakane et al, 2007; Topham and Epand, 2009 ). DGKz and DGKi are two closely related type IV DGKs. DGKz has recently been shown to interact with postsynaptic density (PSD)-95, an abundant postsynaptic scaffolding protein (Sheng and Hoogenraad, 2007; Keith and El-Husseini, 2008) , and regulate the maintenance of dendritic spines and excitatory synapses by regulating postsynaptic DAG signalling (Frere and Di Paolo, 2009; Kim et al, 2009a, b) .
DGKi shares an identical domain structure with DGKz, including the C-terminal PDZ domain-binding motif (Bunting et al, 1996; Ding et al, 1998a, b) . This suggests that DGKi might also bind PSD-95 and regulate synaptic structure and function. In addition, DGKi negatively regulates RasGRP3/ CalDAG-GEFIII (Regier et al, 2005) , a brain-expressed DAG effector with guanine nucleotide exchange factor activity for Ras and Rap small GTPases (Yamashita et al, 2000) , which are known to regulate synaptic/spine structure and synaptic plasticity (Pak et al, 2001; Zhu et al, 2002; Pak and Sheng, 2003) .
Here, we report that DGKi interacts with PSD-95 family proteins, and that this interaction promotes synaptic localization of DGKi. Deficiency of DGKi in mice has no effect on dendritic spines. Rather, DGKi À/À mice show a small increase in presynaptic release probability. In addition, mGluRdependent long-term depression (mGluR-LTD) is reduced in neonatal (2 weeks) DGKi À/À mice through presynaptic mechanisms, and is normalized by the inhibition of PKC. These results indicate that DGKi regulates presynaptic DAG signalling and neurotransmitter release during mGluR-LTD, which sharply contrasts with the prominent postsynaptic functions of the close relative DGKz.
Results

PSD-95 family proteins interact with and promote synaptic localization of DGKi
We have recently reported that DGKz, a close relative of DGKi, interacts directly with the PDZ domain of PSD-95 (Kim et al, 2009b ). We thus first tested whether DGKi also interacts with PSD-95. We found that DGKi forms a complex with PSD-95 and three other PSD-95 family proteins (PSD-93/ chapsyn-110, SAP97, and SAP102) in HEK293 cells . In contrast, a DGKi mutant that lacks the C-terminal PDZ-binding motif (DGKi D3) showed no, or substantially weakened, interactions with PSD-95 family proteins. DGKi also formed a complex with PSD-95 and three other PSD-95 family proteins in rat brain lysates ( Figure 1E -I). DGKi exogenously expressed alone in cultured hippocampal neurons showed a diffuse distribution pattern throughout the neuron regardless of its possession of the PSD-95-binding C-terminus, likely due to its overexpression (Figure 1J and K) . However, when DGKi was coexpressed with PSD-95, the spine localization of DGKi, determined by the spine/dendrite ratio of the protein, was significantly increased. In contrast, the mutant DGKi D3 coexpressed with PSD-95 showed a diffuse distribution similar to that of singly expressed DGKi. These results suggest that PSD-95 promotes synaptic localization of DGKi.
Expression patterns of DGKi protein in the rat brain
We next examined the expression patterns of DGKi protein in the rat brain using an anti-DGKi polyclonal antibody generated for this study. This antibody recognized a major B115 kDa band in the brain, a size similar to that of HA-DGKi expressed in HEK293T cells (Supplementary Figure S1A) , and did not cross-react with DGKz (Supplementary Figure S1B) , indicating that it is specific to DGKi. In addition, this antibody did not detect the DGKi protein in brain lysates from DGKi À/À mice (Supplementary Figure S1C) , further confirming its specificity.
In a series of immunoblot analyses, DGKi protein expression was found mainly in the brain, and not in other tissues ( DGKi expression gradually increased, similar to the expression pattern of PSD-95 ( Figure 2C ). In subcellular fractions of rat brains, DGKi was detected in synaptic fractions, including the crude synaptosomal (P2) and synaptic membrane (LP1) fractions ( Figure 2D ). DGKi proteins in the P2 fraction were similarly partitioned to LP1 and LP2 (synaptic vesicleenriched) fractions (44.5±4.1 and 55.5±4.1%, respectively; n ¼ 3 mice). The detection of DGKi in the LP2 fraction suggests that DGKi is present at presynaptic vesicles. DGKi was also detected in other fractions, including the cytosolic (S3) and microsomal (P3) fractions, suggesting that DGKi protein is widespread at various subcellular sites. DGKi was highly enriched in PSD fractions; similar to PSD-95, it was detected in the highly detergent-resistant PSD III fraction ( Figure 2E ), suggesting that DGKi is tightly associated with the PSD. In cultured hippocampal neurons, DGKi immunofluorescence signals were detected in discrete, but often diffuse, structures along neuronal processes that were positive for both MAP2 (dendritic marker) and NF200 (axonal marker) (Figure 2F and G) . DGKi signals were mainly detected at excitatory synaptic sites; DGKi colocalized with the presynaptic protein synapsin I and excitatory postsynaptic proteins PSD-95 and Shank, but not with the inhibitory presynaptic protein GAD65 or the inhibitory postsynaptic protein gephyrin ( Figure 2H -L). These results indicate that DGKi protein is present in both dendrites and axons, and at excitatory, but not inhibitory, synapses.
In mouse brain slices, DGKi immunofluorescence signals were detected in various brain regions including the hippocampus and cerebellum. In the hippocampus, DGKi signals were detected in all subfields (Supplementary Figure S2A-E) . In the cerebellum, DGKi signals were detected in various layers including the Purkinje cell layer (Supplementary Figure S2F) . The authenticity of these signals was supported by the absence of DGKi signals in DGKi À/À slices (Supplementary Figure S2C) .
Ultrastructural localization of DGKi protein
We also determined the ultrastructural localization of DGKi protein in rat brain regions by electron microscopy ( Figure 3 ). In the hippocampal CA1 region, DGKi signals were detected in cell bodies, dendrites, dendritic spines, and axon terminals ( Figure 3A-D) . In axon terminals, DGKi signals colocalized with presynaptic vesicles as well as the presynaptic plasma membrane. In the cerebellar Purkinje and molecular layers, DGKi signals were detected in cell bodies, dendritic spines, and axon terminals ( Figure 3E -G). In the cerebellar granule cell layer, DGKi signals were detected in cell bodies, dendritic shafts, and axon terminals ( Figure 3H and I). These results indicate that the DGKi protein is present in various subcellular regions of neurons in the hippocampus and cerebellum, and at both pre-and postsynaptic sites. I ). D2, G2, and I2 represent enlarged images of the insets in D1, G1, and I1, respectively. DGKi signals, shown as dark DAB precipitates (black arrowheads), are present in the cell body (A), dendritic shafts (D; B), dendritic spines (S; C), and axon terminals (AT; D) of CA1 pyramidal neurons. In the cerebellum, DGKi signals were observed in Purkinje (E) and granule (H) cell bodies. In the cerebellar molecular layer, DGKi localizes to dendritic spines (S; F) and axon terminals (AT; G). In the granule cell layer (I), DGKi localizes to dendritic shafts (D) and axon terminals (AT). White arrowheads in D, G, and I indicate DAB precipitates associated with the synaptic plasma membrane. Scale bars, 2 mm in A, E, and H, and 0.5 mm in B, C, D1, F, G1, and I1, and 0.1 mm in D2, G2, and I2. Quantitative analysis indicated that DGKi signals are present in 13.3 ± 2.5% of axon terminals and 44.2 ± 4.0% of dendritic spines in the hippocampal CA1 region (n ¼ 3 animals for wild type (WT) and knockout (KO); total area analysed, 232.2 mm 2 /animal). In the cerebellar Purkinje and molecular layers, DGKi signals were found in 45.0±3.2% of axon terminals and 13.5 ± 2.2% of spines. In the cerebellar granule cell layer, DGKi signals were found in 44.8 ± 4.9% of axon terminals and 18.8 ± 4.1% of spines. Therefore, subsets of pre-and postsynaptic structures appear to contain DGKi signals, although the measured values may vary depending on the affinity of the antibodies. In addition, the relative distribution of DGKi signals at pre-and postsynaptic sites appears to vary according to the region of the brain observed.
Normal levels of synaptic proteins and spine density and morphology in the DGKi À/À brain
The ultrastructural localization of DGKi at synaptic sites led us to test whether DGKi regulates synaptic structure or function, using the previously described DGKi À/À mice (Regier et al, 2005) . We first compared expression levels of known pre-and postsynaptic proteins in WT and KO mice, but were unable to detect any significant changes in the expression levels of these proteins ( Figure 4A ). Expression levels of other DGK isoforms (DGKz, DGKg, and DGKy) were unchanged in DGKi À/À mice ( Figure 4B ). Notably, however, DGKi À/À mice showed a significant increase in the expression levels of SNAP-25 ( Figure 4A ), a t-SNARE protein known to regulate presynaptic release (Washbourne et al, 2002; Sorensen et al, 2003; Sudhof, 2004) .
As spine density is significantly reduced in DGKz À/À mice (Kim et al, 2009b) , we investigated spine phenotypes in DGKi À/À mice. Dendritic spines were visualized by biolistic delivery of the lipophilic dye DiI to apical dendrites (stratum radiatum) of hippocampal CA1 pyramidal neurons (Gan et al, 2000) . Surprisingly, there was no significant difference between the spine density in DGKi À/À brains (6.40 ± 0.40 spines/10 mm) and WT brains (7.50 ± 0.50; Figure 5A and B). In addition, DGKi KO caused no change in the length (WT, 1.26±0.03 mm; KO, 1.32±0.05), width (WT, 0.75±0.01; KO, 0.75±0.01), or head area (WT, 0.38±0.01 mm 2 ; KO, 0.38 ± 0.01) of dendritic spines ( Figure 5C -E). These results indicate that DGKi deficiency has no effect on the density or morphology of dendritic spines. This contrasts sharply with the marked reduction in spine density observed in DGKz À/À mice (Kim et al, 2009b) , a difference that is particularly striking given the identical domain structure of the two proteins.
Enhanced evoked excitatory transmission and a small increase in neurotransmitter release probability at DGKi À/À Schaffer collateral-CA1 synapses
The absence of an effect of DGKi KO on dendritic spines does not exclude the possibility that DGKi regulates synaptic functions, considering the well-known involvement of DGKiinteracting PSD-95 family proteins in regulating synaptic functions Sheng and Hoogenraad, 2007) . We thus investigated whether excitatory transmission was changed in the DGKi À/À brain by measuring miniature excitatory postsynaptic currents (mEPSCs) from DGKi
CA1 pyramidal neurons. However, both the frequency and amplitude of mEPSCs in DGKi À/À neurons (frequency, 0.13 ± 0.02 Hz; amplitude, 26.5 ± 1.6 pA) were similar to those in WT neurons (frequency, 0.10 ± 0.02 Hz; amplitude, 28.2±2.9; Figure 5F -H). In addition, the ratio of AMPA receptor-and NMDA receptor-mediated evoked EPSCs (AMPA/NMDA ratio) at Schaffer collateral (SC)-CA1 pyramidal (CA1) synapses in DGKi À/À mice (1.65 ± 0.32) was similar to that in WT mice (1.34 ± 0.20; Figure 5I and J). We next used extracellular recordings to investigate whether DGKi deficiency caused any change in evoked synaptic transmission. Intriguingly, the relationship between fibre-volley amplitude and postsynaptic response (input-output curve) was significantly increased at DGKi À/À SC-CA1 synapses ( Figure 5K ). There were no changes in the relationship between fibre-volley amplitudes and stimulus intensities (Supplementary Figure S3) . These results suggest that AMPA receptor-mediated synaptic transmission was increased at DGKi À/À SC-CA1 synapses, which is not caused by increased excitability of presynaptic fibres. Paired-pulse facilitation (PPF) at DGKi À/À SC-CA1 synapses was largely normal compared with that at WT synapses, except for a small decrease observed at a 20-ms inter-stimulus interval (1.48 ± 0.03 in WT versus 1.59 ± 0.03 in KO; Po0.05; Figure 5L ). As these measurements were made using slices from 3-to 5-week-old mice, we made additional PPF measurements using slices from 2-to 6-week-old mice. Although SC-CA1 synapses from 2-weekold, but not 6-week-old, DGKi À/À slices exhibited a relatively clear tendency for a decrease in PPF, these differences did not reach statistical significance (Supplementary Figure S4A and B). As 2-and 3-5-week-old slices showed clearer tendencies À/À mice relative to WT mice (7-9 weeks). n ¼ 4-5 for A2, and 3 for A3 and B panels. *Po0.05, Student's t-test. towards a decrease in PPF than those from 6-week-old slices, we combined data from these samples (2-5 weeks) and were able to observe an even larger and more significant decrease in PPF (Po0.01; Supplementary Figure S4C ). These results suggest that DGKi deficiency has a small effect on presynaptic release, with changes occurring at earlier developmental stages (2-5 weeks) and at particular inter-stimulus intervals. This increase in presynaptic release, although small, may partly contribute to the increase in synaptic transmission indicated in the input-output curve ( Figure 5K ).
Enhanced MK-801-induced decay in NMDA receptormediated EPSCs at DGKi À/À hippocampal autapses
To examine the function of DGKi in the presynaptic terminalrelease machinery, we assessed glutamatergic synaptic transmission in individual hippocampal neurons from WT and DGKi À/À mice in autaptic culture (Jockusch et al, 2007) , measuring EPSC amplitude, readily releasable pool (RRP) size, and vesicular release probability (P vr Figure 6A and B). In contrast, RRP and P vr were normal at DGKi À/À autapses; the size of the RRP, defined as vesicles whose release can be triggered by the application of a hypertonic buffer containing 0.5 M sucrose (Jockusch et al, 2007) , was 0.61 ± 0.05 nC (n ¼ 127 cells) in DGKi À/À neurons and 0.51 ± 0.04 nC (n ¼ 119) in WT neurons ( Figure 6A and C); and P vr calculated by dividing the charge transfer during a single EPSC by RRP size was 7.70±0.45% (n ¼ 127) in DGKi À/À neurons and 6.90±0.33% (n ¼ 119) in WT neurons ( Figure 6D and E).
To determine whether quantal size was altered in DGKi À/À SC-CA1 synapses. The synaptic input-output relationship was obtained by plotting the slopes of evoked fEPSPs against fibre-volley amplitudes. The inset compares the average input-output ratios of WT and KO synapses. WT, n ¼ 33, 13; KO, 32, 13; **Po0.01, Student's t-test. 3-5 weeks. (L) A small decrease in paired-pulse facilitation (PPF) at DGKi À/À SC-CA1 synapses. The ratios of paired-pulse responses (second fEPSP slope/first fEPSP slope) were plotted against inter-stimulus intervals (in ms). Note that a significant difference is observed at 20 ms inter-stimulus interval. WT, n ¼ 18, 10; KO, n ¼ 19, 11; 3-5 weeks; *Po0.05, Student's t-test.
analysed: WT, 895 ± 128, n ¼ 43; KO, 1108 ± 161, n ¼ 45). There were no changes in short-term plasticity observed during the train of action potentials ( Figure 6I and J).
As DGK is likely essential for regulation of synaptic strength by the Munc13-related pathway, we examined the function of Munc13 in the synaptic release machinery by measuring potentiation of glutamate release by phorbol 12,13-dibutyrate (PDBu) in WT and DGKi À/À neurons. The potentiation ratios were identical for WT and DGKi À/À neurons ( Figure 6K ). In addition, treatment of neurons with the PKC inhibitors bisindoylmaleimide I and Ro-31-8220 (Gordge and Ryves, 1994; Rhee et al, 2002; Wierda et al, 2007) of the slow component in KO neurons (t s ¼ 29.2±4.02 s, n ¼ 12) compared with WT neurons (t s ¼ 78.8 ± 15.7 s, n ¼ 12; Po0.01, Student's t-test); in contrast, the fast component was not significantly altered by DGKi KO (t f ¼ 4.12±0.56 s in KO versus t f ¼ 5.16±0.87 s in WT; Figure 6L-N) . Thus, despite the fact that the proportions of each component (fast and slow) were identical between the two different neurons (WT, t f ¼ 80.0 ± 5.31%, t s ¼ 19.2 ± 5.23%, n ¼ 6; KO, t f ¼ 79.5 ± 3.85%, t s ¼ 20.5 ± 3.86%, n ¼ 6), the synaptic release probability was higher in DGKi À/À neurons than in WT neurons.
Reduced mGluR-dependent LTD at neonatal, but not adult, DGKi À/À SC-CA1 synapses
We next tested whether DGKi deficiency caused any changes in synaptic plasticity. DGKi À/À mice showed normal longterm potentiation (LTP) induced by theta burst stimulation (TBS) at SC-CA1 synapses ( Figure 7A ). In addition, LTD induced by single-pulse, low-frequency stimulation (SP-LFS) was normal in these mice ( Figure 7B ). SP-LFS-induced LTD is known to involve both NMDA receptors and mGluRs (Oliet et al, 1997; Nicoll et al, 1998) . To isolate mGluR-dependent LTD, we used two different methods to activate mGluRs: direct stimulation with (RS)-3,5-dihydroxyphenylglycine (DHPG), a group I mGluR agonist (Palmer et al, 1997; Fitzjohn et al, 1999) , and pairedpulse, low-frequency stimulation (PP-LFS) (Kemp et al, 2000) . LTD is induced differentially at pre-or postsynaptic loci by mGluR activation depending on the developmental stage of the brain; in neonatal stages, presynaptic mGluR-LTD is predominant, whereas postsynaptic mGluR-LTD dominates in adolescent stages (Bolshakov and Siegelbaum, 1994; Oliet et al, 1997; Fitzjohn et al, 2001; Zakharenko et al, 2002; Feinmark et al, 2003; Rammes et al, 2003; Nosyreva and Huber, 2005) , although mGluR-LTD at adult slices also involve presynaptic mechanisms (Fitzjohn et al, 2001; Watabe et al, 2002; Rammes et al, 2003; Rouach and Nicoll, 2003; Tan et al, 2003; Moult et al, 2006) . In experiments performed using hippocampal slices from neonatal (12-14 days) mice, we found that LTD induced at SC-CA1 synapses by DHPG treatment was significantly reduced by B55% in DGKi À/À slices (86.0 ± 4.1%) compared with WT synapses (68.6 ± 3.4%; Po0.01; Figure 7C ). In contrast, LTD induced by treatment of adolescent (4-5 weeks) DGKi À/À slices with DHPG was normal ( Figure 7D ). Consistent with this, when PP-LFS, which mainly triggers postsynaptic mGluR-LTD (Kemp et al, 2000) , was administered to 8-week-old DGKi
slices, it induced LTD that was indistinguishable from that WT, 78.6 ± 2.6%, n ¼ 10, 5; KO, 73.9 ± 2.8%, n ¼ 12, 4. (C) Reduced DHPG (100 mM; RS form)-induced LTD at neonatal (P14-15) DGKi À/À SC-CA1 synapses. WT, 68.6 ± 3.4%, n ¼ 7, 4; KO, 86.0 ± 4.1%, n ¼ 10, 4; **Po0.01, Student's t-test. (D) Normal DHPG-LTD at adolescent (4-5 weeks) DGKi À/À SC-CA1 synapses. WT, 89.9 ± 3.0%, n ¼ 10, 4; KO, 88.7 ± 2.3%, n ¼ 13, 4. (E) Normal PP-LFS-induced LTD at DGKi À/À SC-CA1 synapses (8 weeks). PP-LFS, 900 pairs of 1 Hz stimuli with 50 ms inter-stimulus intervals. WT, 83.3±4.1%, n ¼ 12, 7; KO, 84.0±3.3%, n ¼ 14, 7.
in WT mice ( Figure 7E ). These results suggest that DGKi deficiency selectively attenuates presynaptic mGluR-dependent LTD at neonatal (2 weeks) SC-CA1 synapses.
Reduced DHPG-LTD at neonatal DGKi
À/À synapses involves suppression of an increase in PPF To determine whether the reduction in mGluR-dependent LTD in the neonatal DGKi À/À hippocampus involves presynaptic mechanisms, we measured PPF 10 min before and 60 min after the induction of DHPG-induced mGluR-LTD (DHPG-LTD) at SC-CA1 synapses from 2-week-old mice ( Figure 8A ). Before DHPG treatment, both WT and DGKi À/À slices showed comparable PPF patterns (Supplementary Figure S4A) . After the induction of DHPG-LTD, PPF in WT slices was significantly increased at five inter-stimulus intervals (20, 40, 80, 160, and 320 ms) ( Figure 8B ), consistent with the previous reports (Fitzjohn et al, 2001; Watabe et al, 2002; Rouach and Nicoll, 2003; Tan et al, 2003) . DGKi À/À slices showed increases in PPF at two inter-stimulus intervals (320 and 640 ms; Figure 8C ). Given that the degree of PPF tends to decline as an exponential function of time at intervals o 200 ms, but not at longer intervals (Creager et al, 1980) , these results suggest that there is a smaller increase in PPF at DGKi À/À synapses relative to WT synapses. This difference was paralleled by a significant reduction in DHPG-LTD at DGKi À/À synapses relative to WT synapses ( Figure 8D ). PPF at adult (6 weeks) WT SC-CA1 synapses was also significantly increased by DHPG treatment (Figure 8E) , whereas PPF at DGKi À/À synapses was similar to that in À/À (C) SC-CA1 synapses before and after DHPG-LTD. Note that the increase in PPF during DHPG-LTD is suppressed at DGKi À/À SC-CA1 synapses. Data from panels B, C, E, and F (before DHPG) were used to generate Supplementary Figure S4A and B. WT, n ¼ 11 slices from four mice; KO, n ¼ 12, 4; *Po0.05, **Po0.01, ***Po0.001; Student's t-test. (D) Reduced DHPG-LTD at neonatal DGKi À/À SC-CA1 synapses. WT, 63.8±4.7%, n ¼ 11, 4; KO, 77.9±3.5%, n ¼ 12, 4; ***Po0.001, Student's t-test. (E, F) PPF patterns measured before and after DHPG-LTD at adult (6 weeks) WT (E) and DGKi À/À (F) SC-CA1 synapses. Note that the increase in PPF during DHPG-LTD is suppressed at DGKi À/À SC-CA1 synapses. WT, n ¼ 9, 4; KO, n ¼ 9, 4; *Po0.05, **Po0.01, ***Po0.001; Student's t-test. (G) Comparable DHPG-LTD at adult WT and DGKi À/À SC-CA1 synapses. WT, 83.5 ± 4.4%, n ¼ 9, 4; KO, 89.4 ± 3.7%, n ¼ 9, 4; P ¼ 0.35, Student's t-test.
untreated synapses ( Figure 8F ). These results suggest that DHPG-LTD at adult synapses also involves presynaptic mechanisms, although to a lesser extent than at neonatal synapses, consistent with previous reports (Fitzjohn et al, 2001; Watabe et al, 2002; Rammes et al, 2003; Rouach and Nicoll, 2003; Tan et al, 2003; Moult et al, 2006) . However, DHPG-LTD at DGKi À/À synapses was comparable with that at WT synapses ( Figure 8G ), likely due to the relatively small increase in PPF at WT synapses. These results suggest that the reduced DHPG-LTD at neonatal (2 weeks) DGKi À/À SC-CA1 synapses involves suppression of the increase in PPF associated with mGluR-LTD.
Inhibitors of the C1 domain and PKC normalize PPF and DHPG-LTD at neonatal DGKi À/À synapses
The reduction in mGluR-LTD at DGKi À/À SC-CA1 synapses may reflect an increase in local DAG concentration and enhanced action on presynaptic DAG effectors. One way to address this question would be to directly test whether the levels of PA, a product of DGK action on DAG, are reduced under basal or DHPG-treated conditions, as previously described (Kim et al, 2009b) . However, basal PA levels were not different between WT and DGKi À/À hippocampal slices (Supplementary Figure S6A and B). In addition, DHPG treatment did not lead to a differential fold increase in PA levels relative to basal levels in WT and DGKi Figure S6D-F) . These results might be an indication that DGKi is a less important mediator of presynaptic DAG-to-PA conversion, or that DGKi deficiency can easily be compensated by other DGKs. Alternatively, DGKi may have a major function in presynaptic DAG-to-PA conversion, but the amount of this conversion is relatively small compared with that occurring at postsynaptic sites. To address this issue further, we used chemical inhibitors of DAG action, namely calphostin C (C1-domain inhibitor) and Ro-31-8220 (a PKC inhibitor), administered during the entire recording periods. When PPF was measured in the presence of calphostin C before DHPG treatment in neonatal (2 weeks) slices, PPF patterns at WT and DGKi À/À SC-CA1 synapses were comparable ( Figure 9A and B), indicating that calphostin C treatment itself has little effect on PPF under basal conditions. After DHPG treatment, WT slices showed a normal enhancement in PPF ( Figure 9C ), similar to the PPF increase in the absence of calphostin C ( Figure 8B ). Interestingly, DHPG-induced PPF was significantly increased at calphostin C-treated DGKi À/À synapses ( Figure 9D ), similar to WT synapses ( Figure 9C ). Consistent with this, the magnitudes of DHPG-LTD at WT and DGKi À/À synapses were comparable with each other ( Figure 9E ). This suggests that C1-domain-containing effectors of DAG may be responsible for the reduced DHPG-LTD at DGKi À/À SC-CA1 synapses.
We then repeated the same experiments in the presence of Ro-31-8220. After Ro-31-8220 treatment and before DHPG treatment, PPF at WT and DGKi À/À synapses were indistinguishable ( Figure 9F and G). After DHPG treatment, PPF was similarly, and significantly, increased at Ro-31-8220-treated DGKi À/À and WT synapses ( Figure 9H and I). This increase was paralleled by comparable magnitudes of DHPG-LTD at WT and DGKi À/À synapses ( Figure 9J ). These results collectively suggest that PKC has an important function in reducing DHPG-LTD at neonatal (2 weeks) DGKi À/À SC-CA1 synapses.
Slow habituation, but normal spatial learning and memory, anxiety-like behaviour, and motor coordination, in DGKi À/À mice
We next used the Morris water-maze assay to test whether DGKi deficiency caused any changes in spatial learning and memory behaviour in mice. During the acquisition phase, WT and DGKi À/À mice showed similar escape latencies to find the hidden platform ( Figure 10A ). In the probe test performed 24 h after the training phase, WT and DGKi
mice spent similar amounts of time in the target quadrant where the platform was formerly located ( Figure 10B ). In addition, similar numbers of exact crossings over the region where the platform had been located were observed in WT and DGKi À/À mice ( Figure 10C ). These results indicate that In the elevated plus-maze assay, the time spent by DGKi
mice in open and closed arms was similar to that of WT mice ( Figure 10H ). In addition, both WT and KO mice entered open and closed arms with similar frequencies ( Figure 10I ). These results suggest that DGKi À/À mice have normal levels of anxiety. In the rotarod assay, DGKi À/À mice showed similar levels of motor learning over the course of a 6-day training period ( Figure 10J ). Taken together, these results indicate that DGKi À/À mice are slower to habituation to a novel environment, but have normal levels of locomotor activity, anxiety, and motor coordination.
Discussion
Interaction of DGKi with PSD-95 family proteins
We have identified a novel PDZ-mediated interaction of DGKi with all four known PSD-95 family proteins that occurs both in vitro and in vivo. In addition, we found that DGKi is highly enriched in PSD fractions. We thus initially expected that PSD-95, a member of the PSD-95 family highly enriched at excitatory postsynaptic sites, might promote postsynaptic localization of DGKi for local DAG removal, as previously reported for DGKz (Kim et al, 2009b) . Contrary to this expectation, our results suggest that DGKi may have minimal functions at postsynaptic sites, as shown by the lack of changes in dendritic spines in DGKi À/À mice. It is thus Figure 9 Inhibitors of the C1 domain and PKC normalize PPF and DHPG-LTD at neonatal (2 weeks) DGKi À/À synapses. (A) A diagram depicting PPF measurement 10 min before and 60 min after the induction of mGluR-LTD by DHPG (100 mM) treatment; the C1-domain inhibitor calphostin C (1 mM) was present during the entire recording period. (B) Calphostin C has no effect on PPF before DHPG treatment at neonatal WT and DGKi À/À SC-CA1 synapses. The 'before-DHPG' data from panels C and D were used to generate this figure. (C, D) Calphostin C normalizes the DHPG-induced increase in PPF at neonatal DGKi À/À SC-CA1 synapses (D), to an extent that mimics the pattern of PPF change at WT synapses (C). WT, n ¼ 11 cells from three mice; KO, n ¼ 9, 3; *Po0.05, **Po0.01, ***Po0.001; Student's t-test. (E) Normal DHPG-LTD at neonatal DGKi À/À SC-CA1 synapses in the presence of calphostin C. WT, 78.3±3.6%; KO, 74.8±6.0% (WT, n ¼ 11, 3; KO, n ¼ 9, 3). (F) A diagram depicting PPF measurement 10 min before and 60 min after the induction of mGluR-LTD by DHPG (100 mM) treatment; the PKC inhibitor Ro-31-8220 (1 mM) was present during the entire recording period. (G) Ro-31-8220 has no effect on PPF before DHPG treatment at neonatal WT and DGKi À/À SC-CA1 synapses. The 'before-DHPG' data in panels H and I were used to generate this figure. (H, I) Ro-31-8220 normalizes the DHPG-induced increase in PPF at neonatal DGKi À/À SC-CA1 synapses (I), to an extent that mimics the pattern of PPF change at WT synapses (H). (J) Normal DHPG-LTD at neonatal DGKi À/À SC-CA1 synapses in the presence of Ro-31-8220. WT, 64.8±1.8%, n ¼ 9, 3; KO, 62.4±2.0%, n ¼ 10, 3.
possible that the loss of DGKi in dendritic spines might be compensated by DGKz, a close relative of DGKi, although it seems that the lack of DGKz cannot be compensated by DGKi (Kim et al, 2009b) .
A notable feature of DGKi is that it is present in axons and presynaptic sites in addition to dendrites. This notion is supported by light and electron microscopic data, and by biochemical evidence for localization of DGKi to the synaptic vesicle (LP2) fraction, which contains many presynaptic proteins. More importantly, the loss of DGKi in mice is accompanied by several presynaptic functional abnormalities. DGKi interacts with all four known PSD-95 family proteins; of these, SAP97 and SAP102 are readily detected in axons, in addition to dendrites (Muller et al, 1995; El-Husseini et al, 2000; Aoki et al, 2001; Mok et al, 2002) . Therefore, it is conceivable that DGKi interacts with SAP97 or SAP102 in axonal compartments or at nerve terminals. As SAP97 interacts with the KIF1Ba kinesin motor (Mok et al, 2002) , SAP97 may contribute to axonal transport of DGKi by linking DGKi to microtubule-based motor proteins. PSD-95
and SAP97 are present in distinct nerve terminals in addition to axons and have been implicated in the formation of the cytoskeletal matrix of active zones (Kistner et al, 1993; Kim et al, 1995; Muller et al, 1995; Koulen et al, 1998a, b; Schoch and Gundelfinger, 2006) . It remains to be determined whether DGKi forms a complex with PSD-95 or SAP97 to act in concert at nerve terminals. À/À mice in rotarod assays. Animals were trained 5 min/day for 6 days in the rotarod, and the latencies to fall were quantified (n ¼ 9 for WT and KO; 3-6 months).
mice. This is probably why the change in PPF was not accompanied by the changes in mEPSC or sEPSC frequency. However, we prefer to interpret this as data supporting a small increase in presynaptic release because we could observe a faster MK-801-induced decay of NMDA EPSCs, which is a type of data commonly used, along with PPF, to support that there is a change in presynaptic release probability (Hessler et al, 1993; Rosenmund et al, 1993; Weisskopf and Nicoll, 1995) . In addition, there was a much greater change in PPF during mGluR-LTD at DGKi À/À synapses, which strongly supports the possible involvement of DGKi in the regulation of presynaptic release, although changes in PPF can be induced by diverse causes including postsynaptic modifications (Poncer and Malinow, 2001) . How might DGKi deficiency lead to such a change? The loss of DGKz in dendritic spines suppresses the conversion of DAG to PA (Kim et al, 2009b) . Similarly, the conversion of DAG-generated at nerve terminals by receptor-activated PLC-to PA might be slowed by the lack of DGKi. This would cause an abnormal increase in DAG concentration at the nerve terminal that could promote neurotransmitter release, likely by binding to and stimulating presynaptic DAG effectors. One prominent candidate is Munc13, which is a major downstream effector of DAG (Betz et al, 1998; Brose et al, 2004) and is well known for its role in presynaptic vesicle priming Rosenmund et al, 2003) . Another is PKC, which can contribute to DAG-dependent enhancement of transmitter release (Wierda et al, 2007; Lou et al, 2008) . Alternatively, the lack of DAG-to-PA conversion may lead to a reduced production of PA, which can act as an independent signalling molecule for the regulation of activities or subcellular localization of diverse downstream proteins including p21-activated kinase 1 and phosphatidylinositol-4-phosphate 5-kinase (PI(4)P 5-kinase) (Moritz et al, 1992; Jenkins et al, 1994; Bokoch et al, 1998; Stace and Ktistakis, 2006; Sakane et al, 2007; Kim et al, 2009a) . Whether downstream effectors of PA regulate presynaptic release remains to be determined.
Regulation of mGluR-dependent LTD at neonatal synapses by DGKi
A major phenotypic feature of DGKi À/À mice was a decrease in DHPG-induced mGluR-LTD at neonatal (2 weeks) SC-CA1 synapses. In addition, DGKi À/À synapses do not show a DHPG-induced increase in PPF that is normally observed at WT synapses. Importantly, suppression of the increase in PPF associated with reduced DHPG-LTD at neonatal DGKi
synapses was normalized by inhibitors of the C1 domain and PKC. Quantitatively, the DHPG-induced increase in PPF at a 40-ms inter-stimulus interval is decreased by B70% in DGKi À/À synapses (2 weeks) relative to WT (Figure 8 ). In addition, this decrease was observed in adult (6 weeks) slices, although to a lesser extent (B60%) and at a different inter-stimulus interval (20 ms). In contrast, under basal conditions in the absence of DHPG, only a small (B14%) decrease in PPF (20 ms interval) was observed at 3-5 weeks, but not at 2 or 6 weeks ( Figure 5 ; Supplementary Figure S4A and B). These results suggest that DGKi has an important function in regulating presynaptic release during DHPG-induced mGluR-LTD, whereas it is less important for the regulation of basal release.
What signalling pathways might be involved in the reduction of DHPG-LTD at DGKi À/À synapses and its reversal by PKC inhibition? DHPG-LTD is known to involve, among many suggested mechanisms (Collingridge et al, 2010) , a reduction in presynaptic release (Bolshakov and Siegelbaum, 1994; Oliet et al, 1997; Fitzjohn et al, 2001; Zakharenko et al, 2002; Feinmark et al, 2003; Rammes et al, 2003; Nosyreva and Huber, 2005) . It is, therefore, conceivable that the decreased presynaptic release triggered by mGluR activation is counteracted by the increased presynaptic release caused by DGKi deficiency. An increased tone of DAG at DGKi À/À nerve terminals may act on DAG effectors such as Munc13 and PKC to promote presynaptic release Wierda et al, 2007; Lou et al, 2008) . This suggests that, under normal circumstances, DGKi may have a function in removing DAG at nerve terminals in order to promote a normal decrease in transmitter release during presynaptic mGluR-LTD.
In conclusion, our study identifies PDZ-mediated interactions of DGKi with PSD-95 family proteins, and provides genetic evidence for novel involvements of DGKi in the regulation of presynaptic DAG signalling and neurotransmitter release during mGluR-dependent LTD.
Materials and methods
cDNA constructs and reagents
DGKi cDNAs (full-length, aa 1-1050 and D3, aa 1-1047) were amplified by PCR from a rat brain cDNA library and subcloned into pcDNA3-HA. Full-length rat PSD-93 and mouse SAP102 were subcloned into pEGFP-C1 (Invitrogen). The following constructs have been described: GW1-PSD-95 (Kim et al, 1995) , EGFP-SAP97 (Choi et al, 2005a) , and HA-DGKz (Kim et al, 2009b) . Ro-31-8220 and calphostin C were obtained from Calbiochem and Tocris/ Sigma, respectively.
Antibodies
Polyclonal DGKi antibodies were generated by immunizing guinea pigs (1869 and 1873) and rabbits (1870 and 1871) with GST-DGKi (aa 1-173 for 1869) and GST-DGKi (aa 900-1050 for 1870, 1871, and 1873). Polyclonal antibodies against PSD-95 (1688, guinea pig), PSD-93 (1636, guinea pig), SAP97 (1443, guinea pig), and SAP102 (1447, guinea pig) were generated by using H6-PSD-95 PDZ1-2 (human), GST-PSD-93 (rat full length), GST-SAP97 (rat full length), and GST-SAP102 (mouse full length), respectively. CaMKIIa, b antibodies (rabbit and guinea pig polyclonal 1299 and 1301) were generated using GST-CaMKIIa (human full length) as immunogen. Other antibodies have been described: DGKz (1521) (Kim et al, 2009b) , PSD-95 (SM55) (Choi et al, 2002) , SAP97 (B9591) (Kim and Sheng, 1996) , PSD-93 (1634) (Kim et al, 2009c) , SAP102 (1445) (Choi et al, 2005a) , SynGAP (1682) (Kim et al, 2009c) , CASK (1640) (Kim et al, 2009c) , NR2A (22284), NR2B (21266) (Sheng et al, 1994) , GluR1 (1193), GluR2 (1195) (Kim et al, 2009c) , and panShank (1123) (Lim et al, 2001 ). The following antibodies were purchased from commercial sources: monoclonal PSD-95 (Affinity Bioreagents), HA, EGFP, DGKg (Santa Cruz Biotechnology), synaptophysin, synaptotagmin I, GAP-43, syntaxin 1, a-tubulin, b-actin, MAP2, NF200 (Sigma), synapsin I (Chemicon), GAD65 (Developmental Studies Hybridoma Bank), gephyrin (Synaptic Systems), DGKy, SNAP-25, Rab3 (BD Transduction Laboratories), and NR2A (Zymed).
Animals
Sprague-Dawley rats (280-300 g) were used for rat neuron culture, in vivo coimmunoprecipitation, immunoblot analysis, and electron microscopy. DGKi À/À mice, which were generated using R1 ES cells and back-crossed with C57/BL6, have been previously described (Regier et al, 2005) . WT littermates were used as controls in experiments for immunoblot analyses (Figure 4) , autapses analyses (Figure 6 ), PPF measurements (Figures 8 and 9) , and behavioural analyses (Figure 10) . Other experiments used littermates or age-matched controls.
Coimmunoprecipitation and subcellular and PSD fractions
Transfected HEK293T cells were extracted with phosphate-buffered saline containing 1% Triton X-100 and incubated with HA-agarose (Sigma). For in vivo coimmunoprecipitation, the crude synaptosomal fraction of adult rat brains was solubilized with DOC buffer (50 mM Tris-HCl, 1% sodium deoxycholate, pH 9.0). Subcellular fractions of whole rat brains were prepared as described previously (Huttner et al, 1983) . PSD fractions were purified as described previously (Carlin et al, 1980; Cho et al, 1992) .
Neuron culture, transfection, and analysis of spine localization Cultured rat neurons prepared from embryonic day 18 were maintained in neurobasal medium supplemented with B27 and transfected by the Calphos transfection kit (Invitrogen). Spine localization of DGKi was determined by comparing DGKi signals in a spine and a nearby dendrite; 3-5 spine/dendrite ratios from a single neuron.
Electron microscopy
Hippocampal and cerebellar sections of rat brains (60 mm; 9 weeks) were incubated overnight with DGKi antibodies (1871; 4 mg/ml) and biotinylated secondary antibodies for 2 h. The sections were incubated with ExtrAvidin peroxidase (Sigma), and the immunoperoxidase was revealed by nickel-intensified 3,30-diaminobenzidine tetrahydrochloride. Areas containing the pyramidal cell layer and the stratum radiatum region of the CA1 region of the hippocampus, and the molecular, Purkinje, and granular layers of the cerebellum were trimmed. Images on a Hitachi H 7500 electron microscope (Hitachi) were captured using Digital Montage software driving a MultiScan cooled CCD camera (ES1000W; Gatan).
Electrophysiology
To measure field potentials, 400 mm transverse hippocampal slices were prepared from mice. Slices were left to recover for 1 h before recording in oxygenated (95% O 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl, 5 KCl, 1.23 NaH 2 PO 4 , 26 NaHCO 3 , 10 dextrose, 1.5 MgCl 2 , and 2.5 CaCl 2 . CA1 field potentials evoked by SC stimulation were measured as previously described (Hayashi et al, 2004) . LTP was induced by TBS, which consisted of four trains containing 10 brief bursts (each with four pulses at 100 Hz) of stimuli delivered every 200 ms. LTD was induced by SP-LFS (1 Hz, 900 stimuli), PP-LFS (1 Hz, 900 paired stimuli, stimuli interval of 50 ms), or 10 min application of 100 mM (RS)-DHPG (Tocris). For whole-cell experiments, CA1 pyramidal cells (300 mm horizontal slices) were held at À70 mV using a MultiClamp 700B amplifier (Axon Instruments) with low resistance patch pipettes (2-4 MO). Pipette solutions contained (in mM) 110 Cs-gluconate, 30 CsCl, 20 HEPES, 4 MgATP, 0.3 NaGTP, 4 NaVitC, and 0.5 EGTA (10 EGTA for AMPAR versus NMDAR ratio). For mEPSC measurements, 0.5 mM TTX (Tocris) and 20 mM bicuculline (Tocris) were added to ACSF to inhibit spontaneous action potential-mediated synaptic currents and IPSCs, respectively. We measured mEPSCs for B170 s for each recording (B20 mini-events/ recording); total amounts of time for the recording and the numbers of mini-events analysed were 2169 s and 217, respectively, for WT cells (n ¼ 13) and 3076 s and 400, respectively, for KO cells (n ¼ 18). Data were acquired using Clampex 9.2 (Molecular Devices) and analysed using custom macros written in Igor (Wavemetrics).
Recordings showing 420% changes in series resistance were discarded. For AMPA/NMDA ratio experiments, EPSCs were evoked by electrical stimulation of axons in stratum radiatum at a frequency of 0.06 Hz with electrodes filled with ACSF. AMPARmediated EPSCs were recorded at a holding potential of À70 mV with the same pipette solution as for mEPSC recording, and 100 mM picrotoxin (Tocris) was added to ACSF to inhibit IPSCs. After recording AMPAR-mediated currents, NMDAR-mediated EPSCs were isolated by changing holding potential to þ 40 mV and adding 10 mM CNQX to ACSF. A total of 25-30 EPSCs were averaged to obtain the AMPAR/NMDAR EPSC ratio. Signals were filtered at 2 kHz and digitized at 10 kHz with Digidata 1322A (Axon Instruments).
